Upadacitinib Sustained-release Tablets Reference Listed Drug

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

 

Generic Name	Upadacitinib Sustained-release Tablets
Brand Name	Rinvoq（瑞福）
Dosage Form	Sustained-release Tablet
Strength	15mg
MAH of Product	AbbVie Deutschland GmbH & Co. KG
Note 1	Original drug sold in China
Note 2	Original drug imported to China
Product Type	Reference Listed Drugs (RLDs)

 

Upadacitinib Sustained-release Tablets treat rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, and ankylosing spondylitits. It is also used to treat ulcerative colitis. It works on the immune system. It belongs to a group of medications called JAK inhibitors. It is supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials.

 

We are a global professional supplier of Reference Listed Drug products for pharmaceutical companies conducting clinical trials and CROs, featuring high-quality services and competitive prices. You can get the most favorable Reference Listed Drug prices here. If you have a designated listing country, licensee, or other requirements, please send us the detailed requirements and we will help you purchase through global supplier resources.

 

Email: tosun-global@upharm.cn

Wechat/WhatsApp: (+86)189-2212-0575

Hot Tags: Upadacitinib Sustained-release Tablets Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Alfacalcidol Soft Capsules, Olanzapine Tablets, Reference Listed Drugs, Adefovir Dipivoxil Tablets, Argatroban Injection, Bimatoprost Ophthalmic

• Previous: Pregabalin Extended-release Tablets Reference Listed Drug
• Next: Fampridine Sustained-release Tablets Reference Listed Drug